Immunic (IMUX) Other Non Operating Income (2013 - 2026)
Immunic (IMUX) posted Other Non Operating Income of -$113000.0 for Q1 2026, down 102.95% sequentially from $3.8 million in Q4 2025, and down 109.67% YoY from $1.2 million in Q1 2025.
Powered by 
Analysis
Immunic (IMUX) Other Non Operating Income (2013 - 2026) Analysis & Trends
Immunic has reported Other Non Operating Income for 14 years, with the latest figure at -$113000.0 in Q1 2026.
- Quarterly Other Non Operating Income fell 109.67% year-over-year to -$113000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 million (up 68.65% YoY) and the FY2025 annual result came in at $5.0 million, up 578.17% from the prior year.
- Other Non Operating Income eased to -$113000.0 in Q1 2026 per IMUX's latest filing, from $3.8 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $3.8 million in Q4 2025 and troughed at -$2.1 million in Q1 2024.
- A 5-year average of $260588.2 and a median of $54000.0 in 2023 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2024 and 2025: Other Non Operating Income slumped 277.61% in 2024, then surged 14085.19% in 2025.
- Over 5 years, Other Non Operating Income stood at $155000.0 in 2022, then jumped by 718.06% to $1.3 million in 2023, then tumbled by 97.87% to $27000.0 in 2024, then soared by 14085.19% to $3.8 million in 2025, then tumbled by 102.95% to -$113000.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$113000.0, $3.8 million, and -$5000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | Immunic | 544.60 Mn | 544.60 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -58,000.00 |
| Mar 31, 2026 | -113,000.00 |
| Dec 31, 2025 | 3.83 Mn |
| Sep 30, 2025 | -5,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 27,000.00 |
| Sep 30, 2024 | 582,000.00 |
| Jun 30, 2024 | 436,000.00 |
| Mar 31, 2024 | -2.09 Mn |
| Dec 31, 2023 | 1.27 Mn |
| Sep 30, 2023 | 35,000.00 |
| Jun 30, 2023 | 54,000.00 |
| Mar 31, 2023 | 1.18 Mn |
| Dec 31, 2022 | 155,000.00 |
| Sep 30, 2022 | -1.34 Mn |
| Jun 30, 2022 | -1.40 Mn |
| Mar 31, 2022 | 620,000.00 |
| Dec 31, 2021 | 521,000.00 |
| Sep 30, 2021 | -915,000.00 |